SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-21-004519
Filing Date
2021-04-20
Accepted
2021-04-20 17:00:26
Documents
2
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20210616xpre14a.htm PRE 14A 684010
2 GRAPHIC tmb-20210616xpre14a001.jpg GRAPHIC 5399
  Complete submission text file 0001558370-21-004519.txt   692930
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-32639 | Film No.: 21838614
SIC: 2834 Pharmaceutical Preparations